Carter, Bing Z <br/><br/>
Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5.  [electronic resource] 

 -  Blood  Apr 2008 
 - 3742-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2007-05-091504  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aniline Compounds--agonists<br/>Antineoplastic Agents, Alkylating--agonists<br/>Apoptosis--drug effects<br/>Diterpenes--agonists<br/>Drug Synergism<br/>Epoxy Compounds--agonists<br/>Female<br/>Humans<br/>Imidazoles--agonists<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Phenanthrenes--agonists<br/>Piperazines--agonists<br/>Proto-Oncogene Proteins c-mdm2--antagonists & inhibitors<br/>Receptors, TNF-Related Apoptosis-Inducing Ligand--metabolism<br/>Signal Transduction--drug effects<br/>TNF-Related Apoptosis-Inducing Ligand--agonists<br/>Tumor Suppressor Protein p53--antagonists & inhibitors<br/>U937 Cells<br/>X-Linked Inhibitor of Apoptosis Protein--antagonists & inhibitors